This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Background: Autopsy studies in patients who have been declared brain dead are rare. Total brain necrosis (“respirator brain”) has been a common finding in the distant past. The time to brain fixation has been shortened as a result of timely organ transplant protocols, therefore the neuropathologic findings may be different than previously described.
Methods: We reviewed macroscopic and microscopic brain pathology for ischemic neuronal damage in 41 patients who fulfilled the clinical criteria of brain death. Hematoxylin and eosin stained brain tissue slides were retrieved and available wet tissue was additionally stained to complete a series of samples of the hemispheres, brainstem, and cerebellum for each patient. Neuronal ischemic change was semiquantitatively graded for severity (mild 0 to 5%, moderate >5 to 75%, and severe >75%).
Results: After the clinical diagnosis of brain death and terminal cardiac arrest, 12 brains were fixated in less than 12 hours and 29 brains were fixated between 12 and 36 hours. The frontal lobe, temporal lobe, parietal lobe, occipital lobe, and basal ganglia showed moderate to severe ischemic change in 53 to 68% of the cases. Moderate to severe neuronal ischemic change was found in the thalamus in 34%, midbrain in 37%, pons in 41%, medulla in 40%, and cerebellum in 52% of the cases.
Conclusions: No distinctive neuropathologic features were apparent in our series of patients with brain death. Neuronal ischemic changes were frequently profound, but mild changes were present in a third of the examined hemispheres and in half of the brainstems. Respirator brain with extensive ischemic neuronal loss and tissue fragmentation was not observed. Neuropathologic examination is therefore not diagnostic of brain death.
Glossary
- ICH=
- intracerebral hemorrhage;
- SAH=
- subarachnoid hemorrhage.
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
- Neuropathology of brain death in the modern transplant era
- Neuropathology of brain death in the modern transplant era
- Reply from the authors
- Neuropathology of brain death in the modern transplant era
- Reply from the authors to Machado et al
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
More Online
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg